Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Pat Kendall-Taylor.

Newcastle AuthorsTitleYearFull text
Professor Pat Kendall-Taylor
Dr Petros Perros
Christopher Neoh
Professor Simon Pearce
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO2008
Dr Alison Dickinson
Professor Pat Kendall-Taylor
Dr Petros Perros
Christopher Neoh
Professor Simon Pearce
et al.
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy2008
Professor Anne Dickinson
Professor Pat Kendall-Taylor
Dr Petros Perros
Christopher Neoh
Professor Simon Pearce
et al.
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on the management of GO2008
Dr Karen Adamson
Professor Timothy Cheetham
Professor Pat Kendall-Taylor
Professor Simon Pearce
The role of the IDDM2 locus in the susceptibility of UK APS1 subjects to type 1 diabetes mellitus2007
Dr Petros Perros
Dr Alison Dickinson
Professor Pat Kendall-Taylor
A questionnaire survey on the management of Graves' orbitopathy in Europe2006
Dr Petros Perros
Dr Alison Dickinson
Professor Pat Kendall-Taylor
Christopher Neoh
Clinical assessment of patients with Graves' orbitopathy: The European Group on Graves' orbitopathy recommendations to generalists, specialists and clinical researchers2006
Dr Petros Perros
Professor Pat Kendall-Taylor
Christopher Neoh
A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy2005
Dr Bijayeswar Vaidya
Dr Brian Shenton
Susan Stamp
Dr Alison Dickinson
Dr Petros Perros
et al.
Analysis of peripheral blood T-cell subsets in active thyroid-associated ophthalmopathy: Absence of effect of octreotide-LAR on T-cell subsets in patients with thyroid-associated ophthalmopathy2005
Professor Pat Kendall-Taylor
Dr David Price
Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: Data from KIMS (Pfizer International Metabolic Database)2005
Professor Pat Kendall-Taylor
Dr Petros Perros
Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome2005
Professor Pat Kendall-Taylor
Dr Petros Perros
Early Response to Intravenous Glucocorticoids for Severe Thyroid-Associated Ophthalmopathy Predicts Treatment Outcome.2005
Professor Pat Kendall-Taylor
Dr David Price
The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma2005
Dr Latika Sibal
Dr Stephen Ball
Dr Vincent Connolly
Dr Robert James
Philip Kane
et al.
Pituitary apoplexy: A review of clinical presentation, management and outcome in 45 cases2004
Dr Bijayeswar Vaidya
Dr Helen Imrie
Dr Alison Dickinson
Dr Petros Perros
Professor Pat Kendall-Taylor
et al.
CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism2003
Professor Pat Kendall-Taylor
Dr Petros Perros
Christopher Neoh
Dr Alison Dickinson
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: The first European Group on Graves' Orbitopathy experience2003
Dr Bijayeswar Vaidya
Professor Simon Pearce
Stephen Charlton
Emeritus Professor Drew Rowan
Professor Pat Kendall-Taylor
et al.
An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies2002
Dr Bijayeswar Vaidya
Professor Simon Pearce
Sarah Charlton
Nicola Marshall
Emeritus Professor Drew Rowan
et al.
An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies2002
Professor Pat Kendall-Taylor
Managing differentiated thyroid cancer2002
Professor Pat Kendall-Taylor
Managing differentiated thyroid cancer - Better management can improve survival in this curable cancer2002
Dr Latika Sibal
Professor Pat Kendall-Taylor
Dr Stephen Ball
Dr Robert James
Professor Simon Pearce
et al.
Medical therapy of macroprolactinomas in males: I. prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function2002
Dr Petros Perros
Professor Pat Kendall-Taylor
Medical treatment for thyroid-associated ophthalmopathy2002
Dr Bijayeswar Vaidya
Professor Pat Kendall-Taylor
Professor Simon Pearce
The genetics of autoimmune thyroid disease2002
Dr Bijayeswar Vaidya
Professor Pat Kendall-Taylor
Professor Simon Pearce
The genetics of autoimmune thyroid disease2002
Dr Bijayeswar Vaidya
Dr Helen Imrie
Professor Pat Kendall-Taylor
Professor Simon Pearce
Towards defining the susceptibility loci for Graves’ disease : A UK experience2002
Dr Helen Imrie
Dr Bijayeswar Vaidya
Dr Petros Perros
Dr William Kelly
Dr Eric Young
et al.
Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population2001
Dr Ujjal Mallick
George Proud
Nigel Jones
Dr Helen Lucraft
Dr John Fenwick
et al.
Lack of antigenicity of recombinant human thyrotropin after multiple injections in patients with differentiated thyroid cancer2000
Professor Pat Kendall-Taylor
Janice Gebbie
Dr Stephen Turner
Long-acting octreotide LAR compared with lanreotide SR in the treatment of acromegaly2000
Dr Ujjal Mallick
Dr John Fenwick
Dr Robert James
Dr Sarah Johnson
Professor Pat Kendall-Taylor
et al.
Northern cancer network guidelines for management of thyroid cancer2000
Dr Robert James
Dr Keith Hall
Professor Pat Kendall-Taylor
Optic chiasmal herniation - an under recognized complication of dopamine agonist therapy for macroprolactinoma2000
Dr Ujjal Mallick
Dr Helen Lucraft
George Proud
Dr Petros Perros
Dr John Fenwick
et al.
Optimizing the management of differentiated thyroid cancer.2000
Dr Bijayeswar Vaidya
Professor Simon Pearce
Professor Pat Kendall-Taylor
Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure2000
Professor Pat Kendall-Taylor
Thyroid function tests - Tests must still be done in possible thyroid dysfunction2000
Professor Pat Kendall-Taylor
A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis1999
Professor Mark Thomason
Professor Nick Girdler
Professor Pat Kendall-Taylor
Dr Hilary Wastell
Emeritus Professor Robin Seymour
et al.
An investigation into the need for supplementary steroids in organ transplant patients undergoing gingival surgery: A double-blind, split-mouth, cross-over study1999
Professor Simon Pearce
Dr Bijayeswar Vaidya
Dr Helen Imrie
Dr Petros Perros
Dr William Kelly
et al.
Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease1999
Professor Pat Kendall-Taylor
Alison James
Dr Stephen Ball
Pituitary tumour co-secreting adrenocorticophin and prolactin: clinical, biochemical and radiological response to cabergoline1999
Dr Kelly Britton
Professor Pat Kendall-Taylor
Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome1999
Professor Pat Kendall-Taylor
Relationship of physical exercise and ageing to growth hormone production1999
Professor Pat Kendall-Taylor
Dr Petros Perros
Severe thyroid eye disease associated with primary hypothyroidism and thyroid-associated dermopathy1999
Professor Simon Pearce
Professor Timothy Cheetham
Dr Helen Imrie
Dr Bijayeswar Vaidya
Professor Rudy Bilous
et al.
A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 11998
Dr Robert James
Professor Pat Kendall-Taylor
Professor Thomas Lennard
Gallbladder function in acromegalic patients taking long-term octreotide - evidence of rebound hypermotility on cessation of treatment1992